Φορτώνει......
The clinical utility of circulating tumour cells in patients with small cell lung cancer
Small cell lung cancer (SCLC) accounts for 15% of lung cancer diagnosed worldwide. It is aggressive and characterised by early metastatic spread with rapid development of chemo resistance such that less than 5% of patients diagnosed survive 5 years. Surgery is rarely performed and failure to identif...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Transl Lung Cancer Res |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
AME Publishing Company
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5583068/ https://ncbi.nlm.nih.gov/pubmed/28904885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2017.07.05 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|